SBIR Phase II: Batteryless Wireless Smart Labels with Embedded Non Volatile Memory

该小型企业创新研究第二阶段项目继续开发新型无线微型智能传感器标签，可持续跟踪和记录暴露于环境条件的情况，并将感测数据直接存储在数字CMOS非易失性存储器（NVM）中，而无需任何电池。这些CMOS传感器芯片能够跟踪温度（-50 ° C至70°C），湿度（5%至100%RH）和冲击/冲击（50 g至250 g），总体积小于1.5 mm x 1.5 mm x 0.7 mm。CMOS传感器芯片可以嵌入标准无源射频识别（RFID）嵌体中，以形成能够部署在可扩展RFID网络中的完全集成的多传感器环境条件跟踪无线设备。MEMS器件和数字非易失性存储器的多方面创新方法使所提出的CMOS传感器芯片成为可能。在第一阶段开发的温度和湿度传感器制造和微封装工艺成功地证明了拟议的无线智能传感器标签的技术可行性和商业可行性。拟议努力的结果满足嵌入式和广泛分散的传感器的形状因子，功能和价格点要求，在广泛的应用范围内，该项目的更广泛的影响/商业潜力是对几个现有的行业，更大和更重要的影响，新的市场和行业将围绕这一创新和强大的技术能力形成。我们相信，现有的活/生物材料交付部门可以为Evigia带来高达5亿美元的年销售额，基于我们的技术，每年直接减少高达14亿美元的疫苗效力破坏，每年节省高达1.5亿美元的血浆在运输过程中被破坏。敏感/高价值商品和新鲜农产品的商业交付物流是另一个庞大的现有市场，我们可以在美国每年带来高达50亿美元的直接收益，因为我们的体积更小，成本更低，无电池解决方案被包括在内，以监控在美国运输的所有包裹中更大一部分的运输质量。所提出的努力的基础技术也可能用于开发更广泛的先进系统，包括改善轻度创伤性脑损伤（TBI）的诊断和治疗，每年通过运动和其他意外伤害影响数百万美国人。

This Small Business Innovation Research Phase II project continues the development of a new class of wireless miniature smart sensor labels that continuously track and record exposure to the environmental conditions, and directly store the sensed data in digital CMOS non volatile memory (NVM) without requiring any battery. These CMOS-sensor chips are able to track temperature (-50°C to 70°C), humidity (5% to 100% RH), and shock/impact (50g to 250g), in a total volume of less than 1.5mm x 1.5mm x 0.7mm. The CMOS-sensor chip can be embedded in a standard passive radio frequency identification (RFID) inlay to form a fully integrated multi-sensor environmental condition tracking wireless device that is able to be deployed in a scalable RFID network. A multi-faceted innovative approach in MEMS devices and digital non-volatile memories enables the proposed CMOS-sensor chip. The temperature and humidity sensors fabricated and micropackage processes developed in Phase-I successfully demonstrate the technical feasibility and commercial viability of the proposed wireless smart sensor labels. The outcome of the proposed effort meets the form factor, functionality, and price-point requirements of embedded and widely-dispersed sensing, in a broad range of applications.The broader impact/commercial potential of this project is on several existing industries, larger and more significant impacts on new markets and industries to be formed around this innovative and powerful technical ability. We believe that the existing live/bio material delivery segment can generate up to $500 million yearly sales for Evigia based on our technology directly reducing up to $1.4 billion of vaccine potency destruction each year, and saving up to $150 million yearly of blood plasma being destroyed during transportation. Commercial delivery logistics of sensitive/high-value goods and fresh produce is another large existing market where we can bring direct benefit up to $5 billion yearly in the US based on our smaller, lower cost, batteryless solution being included to monitor shipping quality in a far larger fraction of all packages being shipped in the US. The underlying technology of the proposed effort could be also potentiality employed in development of a broader family of advanced systems including improved diagnosis and treatment of mild traumatic brain injury (TBI) which affects millions of Americans annually through sports and other accidental injuries.